GPX4 and ovarian carcinoma: In addition, the expression of GPX4 and SLC7A11 in platinum‐resistant ovarian cancer cell lines SKOV3 and A2780 can be downregulated by supermagnetic nano‐iron oxide (SPIO) human serum, which can increase the level of ROS in cells and induce ferroptosis in cancer cells [127].